BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The International Society for Vaccines - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The International Society for Vaccines
X-ORIGINAL-URL:https://isv-online.org
X-WR-CALDESC:Events for The International Society for Vaccines
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20250410T010000
DTEND;TZID=UTC:20250410T140000
DTSTAMP:20260413T081748
CREATED:20250327T091743Z
LAST-MODIFIED:20250328T084719Z
UID:4852-1744246800-1744293600@isv-online.org
SUMMARY:NextGen April Webinar
DESCRIPTION:Title: Connecting Ideas with Impact: Building Effective Academia-Industry Alliances\nSpeaker: Dr Balaji Somasundaram\, Denteric Pty Ltd\n\n\nTitle: From bench to business development\,\nSpeaker: Dr Wasan Forsyth\, Vaxxas Pty Ltd\n\nTime: \nUS & Europe: 06:00 (PDT) | 09:00 (EDT) 14:00 (BST) | 15:00 (CEST)\nSouth America: 10:00 (Argentina) | 07:00 (Mexico)\nAfrica: 14:00 (West Africa) | 15:00 (South Africa) | 16:00 (East Africa)\nAsia: 18:30 (IST) | 21:00 (CST) | 22:00 (KST)\nAustralia: 21:00 (AWST) | 23:00 (AEST) | 23:00 (AEDT) \n\n\nJoin the webinar here\n 
URL:https://isv-online.org/event/nextgen-april-webinar/
CATEGORIES:NextGen Webinar Series
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/03/Announcement-NextGen-April-2025-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250424
DTEND;VALUE=DATE:20250425
DTSTAMP:20260413T081748
CREATED:20250124T171555Z
LAST-MODIFIED:20250417T091637Z
UID:3722-1745452800-1745539199@isv-online.org
SUMMARY:RSV Vaccines
DESCRIPTION: SPEAKERS: \n \n  \nGlobal Lifelong Burden of RSV – Louis Bont\, M.D.\, Ph.D\, Professor\, University Medical Center Utrecht \n  \n \n  \nPrefusion-F Stability and Vaccine Efficacy: Structure-Based Vaccines for RSV/HMPV/PIV – Peter Kwong\, Ph.D\, Richard J. Stock Professor\, Biochemistry and Molecular Biophysics Columbia University \n  \n \n  \nPIV5-vectored RSV Intranasal Vaccine (BLB201) is Safe and Immunogenic in Healthy Adults and Young Children\, Hong Jin\, Ph.D\, Chief Scientific Officer\, CynVac/Blue Lake Bio \n  \n \n  \nRSVPreF Vaccine in Older Adults and At-Risk Adults Aged 18 – 59 Years – Kumar Ilangovan\, MD\, MSPH\, MMCi\, FACP\, FAAP\, Director\, Vaccines Clinical Research & Global Clinical Lead\, RSV Adult Vaccine Program\, Pfizer Vaccine \n  \n\nTime: \nUS & Europe: 06:00 (PDT) | 09:00 (EDT) 14:00 (BST) | 15:00 (CEST)\nSouth America: 10:00 (Argentina) | 07:00 (Mexico)\nAfrica: 14:00 (West Africa) | 15:00 (South Africa) | 16:00 (East Africa)\nAsia: 18:30 (IST) | 21:00 (CST) | 22:00 (KST)\nAustralia: 21:00 (AWST) | 23:00 (AEST) | 23:00 (AEDT) \n\n\nJoin the webinar here
URL:https://isv-online.org/event/rsv-vaccines-mini-symposium/
CATEGORIES:Mini-Symposia
ATTACH;FMTTYPE=image/jpeg:https://isv-online.org/wp-content/uploads/2025/01/2025-April-24_Mini-Symposium.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250430T110000
DTEND;TZID=UTC:20250430T170000
DTSTAMP:20260413T081748
CREATED:20250226T090134Z
LAST-MODIFIED:20250407T131545Z
UID:4576-1746010800-1746032400@isv-online.org
SUMMARY:Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against Rift Valley fever in healthy adults
DESCRIPTION:Safety and immunogenicity of the live-attenuated candidate vaccine ‘hRVFV-4s’ against Rift Valley fever in healthy adults \nP.J. (Paul) Wichgers Schreur\, Wageningen Bioveterinary Research\, Netherlands \n  \n\nTime: \nUS & Europe: 08:00 (PDT) | 11:00 (EDT) | 16:00 (BST) |17:00 (CEST)\nSouth America: 12:00 noon (Argentina) | 10:00 (Mexico)\nAfrica: 04:00 (West Africa) | 05:00 (South Africa) | 06:00 (East Africa)\nAsia: 08:30 (IST) | 11:00 (CST) | 12:00 (KST)\nAustralia: 23:00 (AWST) | 01:00 (AEST) 1 May | 20:00 1 May (AEDT) \n\n\nJoin the webinar here\n 
URL:https://isv-online.org/event/safety-and-immunogenicity-of-the-live-attenuated-candidate-vaccine-hrvfv-4s-against-rift-valley-fever-in-healthy-adults/
CATEGORIES:ISV Webinar Series
ATTACH;FMTTYPE=image/png:https://isv-online.org/wp-content/uploads/2025/02/30-April-ISV-Webinar-Announcement.png
END:VEVENT
END:VCALENDAR